GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » ROE %

Invitro International (Invitro International) ROE % : -74.96% (As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Invitro International's annualized net income for the quarter that ended in Jun. 2097 was $-0.79 Mil. Invitro International's average Total Stockholders Equity over the quarter that ended in Jun. 2097 was $1.06 Mil. Therefore, Invitro International's annualized ROE % for the quarter that ended in Jun. 2097 was -74.96%.

The historical rank and industry rank for Invitro International's ROE % or its related term are showing as below:

IVRO's ROE % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -6.965
* Ranked among companies with meaningful ROE % only.

Invitro International ROE % Historical Data

The historical data trend for Invitro International's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International ROE % Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
ROE %
Get a 7-Day Free Trial -600.00 -125.42 -86.27 -66.67 -77.55

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.95 -101.33 -95.24 -136.80 -74.96

Competitive Comparison of Invitro International's ROE %

For the Diagnostics & Research subindustry, Invitro International's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitro International's ROE % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's ROE % distribution charts can be found below:

* The bar in red indicates where Invitro International's ROE % falls into.



Invitro International ROE % Calculation

Invitro International's annualized ROE % for the fiscal year that ended in Sep. 2096 is calculated as

ROE %=Net Income (A: Sep. 2096 )/( (Total Stockholders Equity (A: Sep. 2095 )+Total Stockholders Equity (A: Sep. 2096 ))/ count )
=-1.9/( (2.8+2.1)/ 2 )
=-1.9/2.45
=-77.55 %

Invitro International's annualized ROE % for the quarter that ended in Jun. 2097 is calculated as

ROE %=Net Income (Q: Jun. 2097 )/( (Total Stockholders Equity (Q: Mar. 2097 )+Total Stockholders Equity (Q: Jun. 2097 ))/ count )
=-0.792/( (1.155+0.958)/ 2 )
=-0.792/1.0565
=-74.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2097) net income data. ROE % is displayed in the 30-year financial page.


Invitro International  (OTCPK:IVRO) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2097 )
=Net Income/Total Stockholders Equity
=-0.792/1.0565
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.792 / 0.724)*(0.724 / 1.2825)*(1.2825 / 1.0565)
=Net Margin %*Asset Turnover*Equity Multiplier
=-109.39 %*0.5645*1.2139
=ROA %*Equity Multiplier
=-61.75 %*1.2139
=-74.96 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2097 )
=Net Income/Total Stockholders Equity
=-0.792/1.0565
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-0.792 / -0.792) * (-0.792 / -0.804) * (-0.804 / 0.724) * (0.724 / 1.2825) * (1.2825 / 1.0565)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 0.9851 * -111.05 % * 0.5645 * 1.2139
=-74.96 %

Note: The net income data used here is four times the quarterly (Jun. 2097) net income data. The Revenue data used here is four times the quarterly (Jun. 2097) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Invitro International ROE % Related Terms

Thank you for viewing the detailed overview of Invitro International's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitro International (Invitro International) Business Description

Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.